B

BioStar Ventures

7 employees

BioStar Ventures is a venture capital partnership that focuses on medical device technologies in cardiovascular and orthopaedic medicine.

Investor insights

Sectors invested in

Medical Device27
Health Care25
Medical21
Medical Devices9
Manufacturing8
Health Diagnostics8
Biotechnology7
Wellness5
Robotics5
Office Based Diagnostics5
Sports Medicine5
Orthopedics5
Micro Invasive Visualization5
medical device4
robotics4
software4
Interventional cardiology4
Hypertension Therapy3
Therapeutics3
Non-Invasive3

Funding rounds participated in

$15M sweet spot round size

Most of their 40 investments are in rounds between $7.8M and $25M

Investor type

Venture Capital

Basic info

Industry

venture capital & private equity

Sectors

Angel Investment
Finance
Medical Devices
Orthopaedic Medicine
Venture Capital
Cardiovascular Medicine

Date founded

2003

Investments made

A

AVS Pulse raised $8.8M on April 4, 2023

Investors: CUE Growth Partners and BioStar Ventures

A

AVS Pulse raised $20M on January 5, 2023

Investors: BioStar Ventures

A

AVS Pulse raised $1.2M on October 26, 2022

Investors: BioStar Ventures

R

REVA Medical, Inc. raised $45M on August 9, 2022

Investors: BioStar Ventures

M

MMI S.p.A. raised $75M on July 20, 2022

Investors: Samba Tech, RA Capital Management, L.P., Andera Partners, PANAKES and BioStar Ventures

F

Foldax Inc. raised $20M on June 22, 2020

Investors: Angel Physicians Fund, Caltech, Kairos Ventures and BioStar Ventures

A

Aria CV, Inc. raised $31M on February 25, 2020

Investors: Frontcourt Group, Catalyst Health Ventures, Brightstone Venture Capital, Xeraya Capital, Longview Ventures and BioStar Ventures

C

Corindus Vascular Robotics raised $20M on February 26, 2019

Investors: Hudson Executive Capital and BioStar Ventures

T

Trice Medical raised $18M on January 14, 2019

Investors: Smith & Nephew, Inc., The Charter Group, Safeguard Scientifics, HealthQuest Capital and BioStar Ventures

C

Corindus Vascular Robotics raised $25M on March 16, 2018

Investors: Hudson Executive Capital and BioStar Ventures

FAQ